financetom
Business
financetom
/
Business
/
Hess facing three lawsuits over disclosures in Chevron deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hess facing three lawsuits over disclosures in Chevron deal
May 21, 2024 6:52 AM

May 21 (Reuters) - Oil producer Hess on Tuesday

said it is currently facing three lawsuits alleging inadequate

disclosures over its proposed sale to Chevron ( CVX ).

Chevron ( CVX ) last October offered to acquire Hess in a move to

gain a foothold in oil-rich Guyana's lucrative offshore fields.

However, the deal has been stalled due to a conflict with Exxon

Mobil ( XOM ) and pending regulatory approval by the Federal

Trade Commission.

All three lawsuits seek to further delay or block the $53

billion deal. Hess shareholders are scheduled to vote on May 28

on the deal.

The allegations regarding deficiency in disclosures "are

without merit", the company said in a securities filing on

Tuesday, but added that it was voluntarily supplementing the

proxy statement "to moot plaintiffs' disclosure claims and to

avoid nuisance, potential expense and delay".

In addition to these lawsuits, several purported

stockholders of Hess have sent demand letters alleging similar

deficiencies.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing hones $15 billion financing plan to weather crises, sources say
Boeing hones $15 billion financing plan to weather crises, sources say
Oct 16, 2024
By Shankar Ramakrishnan, Echo Wang and Tim Hepher (Reuters) -Boeing is closing in on a plan to raise around $15 billion with common shares and a mandatory convertible bond as the jetmaker bolsters finances worsened by a crippling strike, but the timing remains unclear, four sources familiar with the matter told Reuters. The company said on Tuesday in regulatory filings...
BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients
BioCryst Pharmaceuticals' Study of Orladeyo Finds Hospitalization Reduction for Hereditary Angioedema Patients
Oct 16, 2024
08:25 AM EDT, 10/14/2024 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Monday a study of berotralstat, which it markets under the brand name of Orladeyo, showed a significant reduction in hospitalizations, emergency room visits, and use of on-demand therapies for patients with hereditary angioedema in the US. The company said that the study of berotralstat will be presented...
BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push -  FT
BRIEF-Uber Explored Possible Bid For Expedia In 'Super App' Growth Push - FT
Oct 16, 2024
Oct 16 (Reuters) - * UBER EXPLORED POSSIBLE BID FOR EXPEDIA IN 'SUPER APP' GROWTH PUSH - FT Source text for Eikon: https://tinyurl.com/22k9lwp7 Further company coverage: ...
Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program
Minerals Technologies Lifts Quarterly Dividend, Sets $200 Million Share Buyback Program
Oct 16, 2024
05:48 PM EDT, 10/16/2024 (MT Newswires) -- Minerals Technologies ( MTX ) said Wednesday it increased its regular quarterly dividend by 10% to $0.11 per share, payable on Dec. 5 to stockholders of record on Oct. 31. The company also said it has been authorized by its board to buy back $200 million of its shares. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved